Envelope proteins as antiviral drug target

Area of Science:

• Virology
• Molecular Biology
• Drug Discovery

Background:

• Virus infection initiates with attachment to host cell receptors, mediated by viral envelope glycoproteins.
• These glycoproteins are essential for viral entry and are the first viral components recognized by the host immune system.

Purpose of the Study:

• To review different classes of viral envelope proteins.
• To emphasize the potential of small molecules as inhibitors of viral envelope protein fusion.
• To highlight envelope proteins as critical drug targets for blocking viral entry.

Main Methods:

• Literature review of viral envelope proteins and their functions.
• Analysis of existing strategies for inhibiting viral entry.
• Focus on small molecule inhibitors targeting envelope protein fusion.

Main Results:

• Viral envelope proteins play a critical role in mediating virus-host cell interactions and entry.
• Currently, limited approved drugs target viral envelope proteins.
• Small molecules demonstrate potential in inhibiting envelope protein-mediated fusion.

Conclusions:

• Viral envelope proteins represent significant targets for antiviral drug development.
• Small molecule inhibitors offer a viable therapeutic approach to block viral infection at its earliest stages.